Citius Pharmaceuticals Inc vs Uranium Energy Corp — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Uranium Energy Corp trades at $11.71 (market cap $5.67B). The key difference: Uranium Energy Corp is far larger — about 283.4× Citius Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| CTXR | UEC | |
|---|---|---|
Market Cap | $20.01M | $5.67B |
Sector | Health | Energy |
52-Week High | $1.82 | $20.14 |
52-Week Low | $0.48 | $9.04 |
Enterprise Value | $16.23M | $5.18B |
Trailing returns across standard periods
Latest headlines on both assets
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →